Short YouTube talk by Joy Kong, MD stating that as stem cells age they secrete fewer anti-inflammatory molecules, lose generational/replicative potential, have reduced potency to differentiate, diminished neuroprotective effects, and decreased ability to detect and kill cancer—implying autologous (self) stem cell therapies may be less effective when cells come from older donors (i.e., the patient).
As we age our stem cells, they will start to secrete less and less anti inflammatory molecules. They will have less and less generations left. So less ability to do its work, they lose the potential to become more types of cells and they also have less neuroprotective effects. And also what's fascinating is that they also lose some important ability to detect cancer and, and kill off cancer. So these are the things we need to understand. So when you do stem cell therapy from your own body, you have to realize what you're putting back in your body is not as ideal as something that's younger and something that has more therapeutic potential.
